TY - CHAP
T1 - Adolescent Metabolic/Bariatric Surgery
T2 - Effects on Obesity, Comorbidities, and Insulin Resistance
AU - Hsia, Daniel S.
AU - Shah, Amy Sanghavi
AU - Inge, Thomas
N1 - Publisher Copyright:
© 2020, Springer Nature Switzerland AG.
PY - 2020
Y1 - 2020
N2 - The high prevalence of severe obesity and data demonstrating childhood obesity tracks into adulthood suggest that these adolescents are at high risk to develop obesity-related comorbidities—such as insulin resistance, type 2 diabetes, obstructive sleep apnea, polycystic ovarian syndrome, fatty liver disease, and cardiovascular disease—by young adulthood. Diet, exercise, and behavior modification have limited success in providing significant and durable weight loss, while pharmacological therapy is currently limited in the pediatric population. Metabolic/bariatric surgery (MBS) in the adolescent population is emerging as an effective long-term option, as it results in sustained weight loss and improves obesity-related comorbidities. This chapter will review common MBS procedures, the indications for use, and the effects of surgery on obesity, associated comorbidities, and insulin resistance in adolescents.
AB - The high prevalence of severe obesity and data demonstrating childhood obesity tracks into adulthood suggest that these adolescents are at high risk to develop obesity-related comorbidities—such as insulin resistance, type 2 diabetes, obstructive sleep apnea, polycystic ovarian syndrome, fatty liver disease, and cardiovascular disease—by young adulthood. Diet, exercise, and behavior modification have limited success in providing significant and durable weight loss, while pharmacological therapy is currently limited in the pediatric population. Metabolic/bariatric surgery (MBS) in the adolescent population is emerging as an effective long-term option, as it results in sustained weight loss and improves obesity-related comorbidities. This chapter will review common MBS procedures, the indications for use, and the effects of surgery on obesity, associated comorbidities, and insulin resistance in adolescents.
KW - Adjustable gastric banding
KW - Adolescent
KW - Cardiovascular disease
KW - Fatty liver disease
KW - Insulin resistance
KW - Metabolic/bariatric surgery
KW - Obstructive sleep apnea
KW - Polycystic ovarian syndrome
KW - Roux-en-Y gastric bypass
KW - Type 2 diabetes
KW - Vertical sleeve gastrectomy
UR - http://www.scopus.com/inward/record.url?scp=85073558564&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=85073558564&partnerID=8YFLogxK
U2 - 10.1007/978-3-030-25057-7_20
DO - 10.1007/978-3-030-25057-7_20
M3 - Chapter
AN - SCOPUS:85073558564
T3 - Contemporary Endocrinology
SP - 335
EP - 346
BT - Contemporary Endocrinology
PB - Humana Press Inc.
ER -
